Potential Antineoplastic Structural Variations of Uracil Mustard (Uramustine) Retaining Cytotoxic Activity and Drug-likeness Suitable for Oral Administration

Journal Title: Journal of Cancer and Tumor International - Year 2015, Vol 2, Issue 2

Abstract

Aims: To present 12 new variants of uracil mustard having drug-like properties and cytotoxic functional group, by utilizing uracil mustard (uramustine) as a lead compound. Utilize rigorous substructure and similarity of a molecular scaffold to determine drug like variants. Physicochemical properties determined indicate the variants have favorable drug-likeness. Study Design: Conduct molecular database search utilizing features of substructure and similarity based upon uracil mustard. Place and Duration of Study: Department of Chemistry, Medicinal Chemistry Study Section, University of Nebraska at Omaha, Omaha Nebraska between January 2015 to March 2015. Methodology: Uracil mustard consists of the pyrimidine derivative uracil, having the bifunctional nitrogen mustard cytotoxic moiety covalently bonded onto the ring. A systematic search, utilizing substructure component and similarity, within an in-silico database search successfully determined 12 variants. Rigorous criteria for drug-likeness was implemented to screen potential candidates that included the application of the Rule of 5. In addition, maintaining the cytotoxic moiety of nitrogen mustard was crucial. Results: A total of 12 variants of uracil mustard was identified after an extensive molecular database search using rigorous criteria. All 12 variants, and including uracil mustard, showed zero violations of the Rule of 5, thereby indicating favorable drug-likeness. Values of polar surface area for all compounds at less than 80 Angstroms2 are suitable for central nervous system penetration. Polar surface area, number of atoms, and Log P for all compounds increased as the molecular weight increases. Structure substituents include nitrogen mustard groups, hydroxyl, alkyl and carbonyl moieties. Cluster analysis discerned greatest similarity among members of this group. Conclusion: Applying rigorous search criteria within a molecular data base, for comparison and reject, successfully identified 12 variants of uracil mustard that show favorable drug-likeness in addition to cytotoxic capability. The design of new antitumor agents is important for increasing efficacy of the clinical treatment of cancer.

Authors and Affiliations

Ronald Bartzatt

Keywords

Related Articles

Carcinosarcoma of Ovary, it’s Histopathological, Management and Prognostic Analysis with Review of Literature

Carcinosarcoma is a mixed malignant biphasic tumour representing a rare entity and comprises of both epithelial and mesenchymal components. Primary ovarian carcinosarcoma is a rare neoplasm with a number of cases reporte...

Bilateral Breast Fibromatosis in a 41 Years Old Woman

Breast fibromatosis is a rare benign tumor of soft tissues with local spread, frequently recurrent but with no metastatic evolutions. We present a case diagnosed in a 41 years old patient referred to a Douala private med...

Evaluation of Cardiac Biomarkers in Detection of Cardiomyopathy Induced by Cardiotoxic Chemotherapeutic Agents

Background: Doxorubicin is a potent chemotherapeutic drug. The clinical usefulness of doxorubicin has been limited largely by the risk of cardiomyopathy and life-threatening heart failure. Therefore early identification...

Antitumour Activity of Xanthium strumarium L. on Human Cervical Cancer HeLa Cells

Aim: The present investigation was aimed at assessing the antiproliferative and apoptotic potential of the hydroalcoholic extract of X. strumarium on HeLa cell line. Study Design: Antitumour activity of Xanthium strumar...

Aggressive Angiomyxoma Presenting as a Recurrent Cervical Polyp – A Case Report

Backgroud: In 1983, Steeper and Rosai first described Aggressive Angiomyxoma. It is a mesenchymal neoplasm of the soft tissue that grows slowly in the pelvis and perineum and infiltrates locally. We present a case of an...

Download PDF file
  • EP ID EP242939
  • DOI 10.9734/JCTI/2015/17780
  • Views 132
  • Downloads 0

How To Cite

Ronald Bartzatt (2015). Potential Antineoplastic Structural Variations of Uracil Mustard (Uramustine) Retaining Cytotoxic Activity and Drug-likeness Suitable for Oral Administration. Journal of Cancer and Tumor International, 2(2), 50-58. https://europub.co.uk/articles/-A-242939